Flagship Ventures 2007 General Partner’s Carisma Therapeutics CARM Stock Holding History

Flagship Ventures 2007 General Partner’s Portfolio CARM Stock Details CARM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$3.2M	Buy	+95,350	New	+$2.41M	2.98%	3
2015 Q4	$5.74M	Hold	95,350	–	–	3.77%	3
2015 Q3	$4.6M	Hold	95,350	–	–	2.89%	3
2015 Q2	$5.38M	Hold	95,350	–	–	2.18%	3
2015 Q1	$17M	Hold	95,350	–	–	8.45%	2
2014 Q4	$22.7M	Hold	95,350	–	–	9.41%	2
2014 Q3	$21.2M	Hold	95,350	–	–	14.99%	2
2014 Q2	$25.1M	Hold	95,350	–	–	21.46%	2
2014 Q1	$31M	Buy	+95,350	New	+$28.6M	13.58%	3

Other funds holding CARM

FVFIGP

Flagship Ventures Fund IV General Partner Cambridge, Massachusetts $585M AUM

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Flagship Ventures 2007 General Partner's CARM Position: Q2 2016 in Review

Flagship Ventures 2007 General Partner opened a new position in Carisma Therapeutics (CARM) in Q2 2016: 95,350 shares worth $3.2M. The stake represents 2.98% of the portfolio and ranks #3 among its holdings. This is a return to the name: Flagship Ventures 2007 General Partner previously reported a position in CARM as recently as Q4 2015.

Flagship Ventures 2007 General Partner first reported a position in CARM in Q1 2014 and has held it in 9 quarters since. The position peaked at $31M in Q1 2014. 25 funds tracked by Wall St. Rank hold CARM as of Q2 2016.

Flagship Ventures 2007 General Partner held 95,350 shares of Carisma Therapeutics worth $3.2M as of Q2 2016.
Carisma Therapeutics was a new Flagship Ventures 2007 General Partner position in Q2 2016.
Carisma Therapeutics made up 2.98% of Flagship Ventures 2007 General Partner's portfolio in Q2 2016, its #3 holding.
Flagship Ventures 2007 General Partner first reported a position in Carisma Therapeutics in Q1 2014 and has held it in 9 quarters since.
Flagship Ventures 2007 General Partner's Carisma Therapeutics position peaked at $31M in Q1 2014.
25 funds tracked by Wall St. Rank held Carisma Therapeutics as of Q2 2016.

Based on Flagship Ventures 2007 General Partner's 13F filing for Q2 2016, filed 15 Aug 2016.